(29 days)
Not Found
No
The device description focuses on mechanical components and the Seldinger technique, with no mention of AI or ML capabilities.
No.
A therapeutic device is one that treats or alleviates a disease or condition. This device is an introducer for catheters, which are used to access the venous system, but the introducer itself does not provide therapy.
No
The device is described as a "catheter introducer device" for "percutaneous insertion of catheters into the venous system," facilitating the placement of in-dwelling intravascular catheters. Its components and function are entirely related to the mechanical act of introducing a catheter, not to diagnosing a patient's condition.
No
The device description clearly outlines physical components like needles, guidewires, dilators, and sheaths, indicating it is a hardware medical device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "percutaneous insertion of catheters into the venous system." This describes a surgical/procedural device used to access the body, not a device used to examine specimens derived from the human body for diagnostic purposes.
- Device Description: The description details components like needles, guidewires, dilators, and sheaths, all of which are tools for accessing and introducing catheters into blood vessels. There is no mention of reagents, calibrators, controls, or any components typically associated with in vitro testing.
- Lack of IVD Keywords: The text does not contain keywords commonly found in IVD descriptions, such as "in vitro," "specimen," "assay," "analyte," "diagnosis," "detection," "measurement," etc.
- Performance Studies: The performance studies described focus on "biological safety and biomechanical performance characteristics," which are relevant to the physical function and safety of a procedural device, not the analytical performance of an IVD.
In summary, the CVC WAND™ is a medical device used for a procedural purpose (catheter insertion), not for performing diagnostic tests on samples outside the body.
N/A
Intended Use / Indications for Use
The CVC WAND™ Safety Introducer with Valved Peelable Sheath is indicated for use in percutaneous insertion of catheters into the venous system.
Product codes (comma separated list FDA assigned to the subject device)
DYB
Device Description
The CVC WAND™ Safety Introducer with Valved Peelable Sheath (hereafter CVC WAND™) is a catheter introducer device that is virtually identical to the predicate device, the CVC WAND™ Safety Introducer with Valved Peelable Sheath, cleared for commercial distribution under 510(k) K131148. When assembled for use, it is an all-inone preassembled intravascular catheter introducer, that provides the clinician with a simple and accelerated approach to the Seldinger Technique for placing in-dwelling intravascular catheters. The device is composed of the following key components:
-
Introducer Needle
-
Guidewire
-
Dilator
-
Valved Peelable Sheath Introducer
The CVC WAND™ includes a 21-gauge microaccess needle, nylon tissue dilator, FEP peelable sheath and Nitinol guidewire. This device has an integrated valve within the body of the Peelable Sheath Introducer hub which is designed to reduce inflow of air into the bloodstream and outflow of blood when the guidewire, introducer needle and dilator are removed, but it is not a hemostasis valve. The device also has a blood flashback window proximal to the needle's tip which allows the clinician to observe blood flashback upon entering the vessel with the Safety Introducer. The microaccess needle is echogenic and provides the pathway for the guidewire insertion, while the dilator facilitates placement of the peelable sheath and ultimately catheter placement.
The CVC WAND™ is individually packaged in a PETG. glvcol modified polyethylene terephthalate, plastic tray. The tray is heat sealed with a Tyvek® lid. The device is provided 'STERILE' (ethylene oxide gas) and is for 'single-use' only.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
venous system
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
A program with designed verification testing, including biocompatibility testing, was conducted to demonstrate the biological safety and biomechanical performance characteristics of the CVC WAND™.
The only device modification was to the Valved Peelable Sheath Introducer component. The modification was a material change to the valve found within the hub of the Valve Peelable Sheath Introducer component. The material of the valve changed from silicone to thermoplastic elastomer. Therefore, biocompatibility testing of this component with the new material was conducted in accordance with the provisions of ISO 10993-1:2009. The results of the biocompatibility testing satisfied the acceptance criteria of the relevant ISO 10993 standards.
Some design verification performance testing was leveraged from the predicate device manufactured by Access Scientific. These specific performance testing were leveraged from the predicate device, cleared for commercial distribution under 510(k) K131148, because these performance criteria of the device were not affected as a result of the material change.
Prospective design verification performance testing conducted for the device modification of CVC WAND™ is:
- Valved Peelable Sheath Introducer: Valve Air Leakage, Valve Liquid Leakage, Valve Flexibility, Valve Patency, Valve Integrity
- Device System: Particulate Matter USP (Reference only)
The results of the design verification performance testing satisfy acceptance criteria identified in applicable standards and/or the device design specification.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1340 Catheter introducer.
(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
September 18, 2018
Access Scientific, LLC Martina Nguyen Regulatory Affairs / Quality Assurance Specialist 3910 Sorrento Valley Boulevard, Suite 200 San Diego, California 92121
Re: K182243
Trade/Device Name: The CVC WAND Safety Introducer with Valved Peelable Sheath Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter Introducer Regulatory Class: Class II Product Code: DYB Dated: August 16, 2018 Received: August 20, 2018
Dear Martina Nguyen:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Misti L. Malone -S
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K182243
Device Name
The CVC WANDSafety Introducer with Valved Peelable Sheath
Indications for Use (Describe)
The CVC WAND Safety Introducer with Valved Peelable Sheath is indicated for use in percutaneous insertion of catheters into the venous system.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(K) SUMMARY
1. SUBMITTER INFORMATION
| Company Name: | Access Scientific, LLC |
|---|---|
| Company Address: | 3910 Sorrento Valley Boulevard |
| Suite 200 | |
| San Diego, CA 92121 | |
| Company Phone: | (858) 259-8333 |
| Company Facsimile: | (858) 259-5298 |
| Contact Person: | Martina Nguyen |
| Regulatory Affairs & Quality Assurance Specialist | |
| mnguyen@accessscientific.com | |
| Date: | August 16, 2018 |
2. PROPOSED DEVICE IDENTIFICATION
| Trade Name: | The CVC WAND™ Safety Introducer with Valved
Peelable Sheath |
|----------------------------|----------------------------------------------------------------|
| Common Name: | Catheter Introducer |
| Classification Name: | Introducer, Catheter |
| Classification Regulation: | 21 CFR 870.1340 |
| Device Class: | Class II |
| Product Code(s): | DYB |
| Advisory Panel: | Cardiovascular |
3. PREDICATE DEVICE IDENTIFICATION
The CVC WAND™ Safety Introducer with Valved Peelable Sheath is substantially equivalent to the following Access Scientific device, which is cleared for commercial distribution under 510(k) K131148:
| Trade Name: | The CVC WAND™ Safety Introducer with Valved |
|---|---|
| Peelable Sheath |
4
| Common Name: | Catheter Introducer |
|---|---|
| Classification Name: | Introducer, Cathete- |
| Classification Regulation: | 21 CFR 870.1340 |
| Device Class: | Class II |
| Product Code(s): | DYB |
| Advisory Panel: | Cardiovascular |
4. DEVICE DESCRIPTION
The CVC WAND™ Safety Introducer with Valved Peelable Sheath (hereafter CVC WAND™) is a catheter introducer device that is virtually identical to the predicate device, the CVC WAND™ Safety Introducer with Valved Peelable Sheath, cleared for commercial distribution under 510(k) K131148. When assembled for use, it is an all-inone preassembled intravascular catheter introducer, that provides the clinician with a simple and accelerated approach to the Seldinger Technique for placing in-dwelling intravascular catheters. The device is composed of the following key components:
-
Introducer Needle
-
Guidewire
-
Dilator
-
Valved Peelable Sheath Introducer
The CVC WAND™ includes a 21-gauge microaccess needle, nylon tissue dilator, FEP peelable sheath and Nitinol guidewire. This device has an integrated valve within the body of the Peelable Sheath Introducer hub which is designed to reduce inflow of air into the bloodstream and outflow of blood when the guidewire, introducer needle and dilator are removed, but it is not a hemostasis valve. The device also has a blood flashback window proximal to the needle's tip which allows the clinician to observe blood flashback upon entering the vessel with the Safety Introducer. The microaccess needle is echogenic and provides the pathway for the guidewire insertion, while the dilator facilitates placement of the peelable sheath and ultimately catheter placement.
The CVC WAND™ is individually packaged in a PETG. glvcol modified polyethylene terephthalate, plastic tray. The tray is heat sealed with a Tyvek® lid. The device is provided 'STERILE' (ethylene oxide gas) and is for 'single-use' only.
5. INDICATION FOR USE
The CVC WAND™ Safety Introducer with Valved Peelable Sheath is indicated for use in percutaneous insertion of catheters into the venous system.
5
6. TECHNOLOGICAL CHARACTERISTICS
The CVC WAND™ has equivalent technological characteristics as the predicate devices in terms of components, design, and performance. The Needle, Guidewire, and Dilator are the same components used in the predicate device. The Valved Peelable Sheath Introducer component is equivalent to the predicate device with the exception of the valve subcomponent found within the hub to reduce the risk of blood and air intake during the catheterization procedure. The valve subcomponent is manufactured with a new material, thermoplastic elastomer, rather then the existing silicone material.
7. SUMMARY OF TESTING
A program with designed verification testing, including biocompatibility testing, was conducted to demonstrate the biological safety and biomechanical performance characteristics of the CVC WANDIM.
The only device modification was to the Valved Peelable Sheath Introducer component. The modification was a material change to the valve found within the hub of the Valve Peelable Sheath Introducer component. The material of the valve changed from silicone to thermoplastic elastomer. Therefore, biocompatibility testing of this component with the new material was conducted in accordance with the provisions of ISO 10993-1:2009 and summarized in Table 4.1. The results of the biocompatibility testing satisfied the acceptance criteria of the relevant ISO 10993 standards.
| Table 4.1: Biocompatibility Testing of the Valved Peelable Sheath Introducer
| Component | |
|---|---|
| Test | Test Method/Standard |
| Cytotoxicity | ISO MEM Elution Using L-929 Mouse |
| Fibroblast Cells (GLP) | |
| ISO 10993-5:2009 | |
| Sensitization | ISO Guinea Pig Maximization Sensitization |
| Test (GLP – 2 Extracts) | |
| ISO 10993-10:2010 | |
| Intracutaneous Reactivity | ISO Intracutaneous Irritation Test (GLP – 2 |
| Extract) | |
| ISO 10993-10:2010 | |
| Acute Systemic Toxicity | USP Systemic Injection (Normal Saline and |
| Cottonseed Oil Extract) | |
| ISO 10993-11:2006 | |
| Hemolysis | ASTM Hemolysis Assay – Direct Contact |
| and Extract Method (GLP) | |
| ISO 10993-4:2002 | |
| Material Mediated Pyrogenicity | Normal Saline Extract |
| ISO 10993-11:2006 | |
| Partial Thromboplastic Time (PTT) | Direct Contact |
Toble 4 1; Riogampotibility Tosting of the Volved Pooloble Shooth Introducar
6
| Component | Test | Test Method/Standard |
|---|---|---|
| ISO 10993-4:2002 | ||
| In Vitro Platelet and Leucocyte Counts | Direct Contact | |
| ISO 10993-4:2002 | ||
| Complement Activation | C3a and Sc5b-9 Complexes | |
| ISO 10993-4:2002 |
Table 4.1: Biocompatibility Testing of the Valved Peelable Sheath Introducer
Some design verification performance testing was leveraged from the predicate device manufactured by Access Scientific and are summarized in Table 4.2. These specific performance testing were leveraged from the predicate device, cleared for commercial distribution under 510(k) K131148, because these performance criteria of the device were not affected as a result of the material change.
Prospective design verification performance testing conducted for the device modification of CVC WAND™ is shown in Table 4.3. The results of the design verification performance testing satisfy acceptance criteria identified in applicable standards and/or the device design specification.
| Table 4.2: Prior Applicable Testing Conducted on the Predicate Device (K131148) | |
|---|---|
| Component | Testing |
| Introducer Needle | • Lumen patency |
| • Tensile strength: tube-to-hub bond | |
| • Air leak/resistance to stress cracking | |
| • Corrosion resistance | |
| Dilator | • Distal Tip Columnar Strength |
| • Strength of Union: Tube-to-Hub | |
| Guidewire | • Fracture testing |
| • Flex testing | |
| • Strength of union: core-to-coil | |
| • Strength of union: wire-to-cap | |
| • Corrosion resistance | |
| Valved Peelable Sheath | |
| Introducer | • Distal Tip Columnar Strength |
| • Strength of Union: Tube-to Hub, Valve-to-Lower-Hub | |
| • Split/Feel Force of Hub/Sheath | |
| Device System | • Axial Forces |
| • “Fast-Flash™” Evaluation | |
| • Insertability | |
| • Needle-stick safety | |
| • Guidewire cap snap-on force |
7
| Table 4.2: Prior Applicable Testing Conducted on the Predicate Device (K131148) | |
|---|---|
| Component | Testing |
| Protective Cover Removal Force – Dilator, Sheath Introducer Needle Cover Functional Evaluation and Removal Force Needle Cover Silicone Migration Evaluation Needle lock to Needle hub separation force |
Table 4.3 Prospective Testing Conducted on the CVC WAND™ Safety Introducer with Valved Peelable Sheath
| Component | Testing |
|---|---|
| Valved Peelable Sheath | |
| Introducer | • Valve Air Leakage |
| • Valve Liquid Leakage | |
| • Valve Flexibility | |
| • Valve Patency | |
| • Valve Integrity | |
| Device System | • Particulate Matter USP |
| (Reference only) |
8. CONCLUSIONS
The test results demonstrate that the device modifications to the CVC WAND™ Safety Introducer with Valved Peelable Sheath is substantially equivalent to the predicate devices in design, function, and indications for use.